• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白(a)和相对低淋巴细胞浓度是 2 型糖尿病患者冠心病的显著独立危险因素:脂蛋白(a)表型、淋巴细胞与冠心病。

Low-molecular-weight lipoprotein (a) and low relative lymphocyte concentration are significant and independent risk factors for coronary heart disease in patients with type 2 diabetes mellitus: Lp(a) phenotype, lymphocyte, and coronary heart disease.

机构信息

Department of Internal Medicine (Divisions of Cardiology, Hepatology, Geriatric Medicine, and Integrated Medicine), Nippon Medical School, 1-1-5, Sendagi, Bunkyo-ku, Tokyo, 113-8603, Japan.

出版信息

Lipids Health Dis. 2013 Mar 7;12:31. doi: 10.1186/1476-511X-12-31.

DOI:10.1186/1476-511X-12-31
PMID:23496967
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3606419/
Abstract

BACKGROUND

The aim of the present prospective study was to examine whether lipoprotein (a) [Lp(a)] phenotypes and/or low relative lymphocyte concentration (LRLC) are independently associated with coronary heart disease (CHD) in patients with type 2 diabetes mellitus (T2DM).

METHODS

Serum Lp(a) concentration, Lp(a) phenotypes, and RLC were analyzed in 214 subjects. Lp(a) phenotypes were classified into 7 subtypes according to sodium dodecyl sulfate-agarose gel electrophoresis by Western blotting. Subjects were assigned to the low-molecular-weight (LMW (number of KIV repeats: 11-22) ) and high-molecular-weight (HMW( number of KIV repeats: >22 )) Lp(a) groups according to Lp(a) phenotype and to the LRLC (RLC: <20.3%) and normal RLC (NRLC; RLC: ≥20.3%) groups according to RLC. A CHD event was defined as the occurrence of angina pectoris or myocardial infarction during the follow-up period.

RESULTS

During the follow-up period, 30 cases of CHD events were verified. Neutrophil count showed no correlation with CHD, while relative neutrophil concentration and RLC showed positive and negative correlations, respectively, with CHD. The Cox proportional hazard model analysis revealed the following hazard ratios adjusted for LMW Lp(a), LRLC, and LMW Lp(a) + LRLC: (4.31; 95% confidence interval [CI], 1.99-9.32; P < 0.01, 3.621; 95% CI, 1.50-8.75; P < 0.05, and 7.15; 95% CI, 2.17-23.56; P < 0.01, respectively).

CONCLUSIONS

Our results suggest that both LMW Lp(a) and LRLC are significant and independent risk factors for CHD and that the combination thereof more strongly predicts CHD in patients with T2DM.

摘要

背景

本前瞻性研究旨在探讨脂蛋白(a)[Lp(a)]表型和/或低相对淋巴细胞浓度(LRLC)是否与 2 型糖尿病(T2DM)患者的冠心病(CHD)独立相关。

方法

分析了 214 例患者的血清 Lp(a)浓度、Lp(a)表型和 RLC。通过 Western 印迹法,根据十二烷基硫酸钠-琼脂糖凝胶电泳将 Lp(a)表型分为 7 种亚型。根据 Lp(a)表型将受试者分为低分子量(LMW(KIV 重复数:11-22))和高分子量(HMW(KIV 重复数:>22))Lp(a)组,根据 RLC 将受试者分为低 RLC(RLC:<20.3%)和正常 RLC(NRLC;RLC:≥20.3%)组。CHD 事件定义为随访期间心绞痛或心肌梗死的发生。

结果

在随访期间,证实了 30 例 CHD 事件。中性粒细胞计数与 CHD 无相关性,而相对中性粒细胞浓度和 RLC 分别与 CHD 呈正相关和负相关。Cox 比例风险模型分析显示,在校正 LMW Lp(a)、LRLC 和 LMW Lp(a)+LRLC 后,以下风险比:(4.31;95%置信区间 [CI],1.99-9.32;P<0.01,3.621;95%CI,1.50-8.75;P<0.05,和 7.15;95%CI,2.17-23.56;P<0.01)。

结论

我们的结果表明,LMW Lp(a)和 LRLC 均为 CHD 的显著和独立危险因素,两者结合可更强烈地预测 T2DM 患者的 CHD。

相似文献

1
Low-molecular-weight lipoprotein (a) and low relative lymphocyte concentration are significant and independent risk factors for coronary heart disease in patients with type 2 diabetes mellitus: Lp(a) phenotype, lymphocyte, and coronary heart disease.载脂蛋白(a)和相对低淋巴细胞浓度是 2 型糖尿病患者冠心病的显著独立危险因素:脂蛋白(a)表型、淋巴细胞与冠心病。
Lipids Health Dis. 2013 Mar 7;12:31. doi: 10.1186/1476-511X-12-31.
2
Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study.脂蛋白(a)作为冠心病的预测指标:PRIME研究
Atherosclerosis. 2002 Aug;163(2):377-84. doi: 10.1016/s0021-9150(02)00026-6.
3
Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus.血清脂蛋白(a)浓度升高对2型糖尿病患者冠心病风险的影响。
Metabolism. 2008 Jun;57(6):791-5. doi: 10.1016/j.metabol.2008.01.020.
4
Impact of markedly elevated serum lipoprotein(a) levels (> or = 100 mg/dL) on the risk of coronary heart disease.血清脂蛋白(a)水平显著升高(≥100mg/dL)对冠心病风险的影响。
Metabolism. 2007 Sep;56(9):1187-91. doi: 10.1016/j.metabol.2007.04.015.
5
Lipoprotein(a) concentrations, apolipoprotein(a) isoforms and clinical endpoints in haemodialysis patients with type 2 diabetes mellitus: results from the 4D Study.2型糖尿病血液透析患者的脂蛋白(a)浓度、载脂蛋白(a)异构体与临床终点:4D研究结果
Nephrol Dial Transplant. 2016 Nov;31(11):1901-1908. doi: 10.1093/ndt/gfv428. Epub 2016 Jan 10.
6
Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease.血浆脂蛋白(a)浓度可预测稳定性冠心病患者未来的冠状动脉和心血管事件。
Arterioscler Thromb Vasc Biol. 2013 Dec;33(12):2902-8. doi: 10.1161/ATVBAHA.113.302479. Epub 2013 Oct 3.
7
A prospective study of lipoprotein(a) and risk of coronary heart disease among women with type 2 diabetes.一项关于2型糖尿病女性脂蛋白(a)与冠心病风险的前瞻性研究。
Diabetologia. 2005 Aug;48(8):1469-76. doi: 10.1007/s00125-005-1814-3. Epub 2005 Jun 22.
8
Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease.载脂蛋白(a)水平和载脂蛋白(a)亚型大小对冠心病风险的影响。
J Intern Med. 2014 Sep;276(3):260-8. doi: 10.1111/joim.12187. Epub 2014 Feb 5.
9
The association of lipoprotein(a) and apolipoprotein(a) phenotypes with peripheral artery disease.脂蛋白(a)和载脂蛋白(a)表型与外周动脉疾病的关联。
Ter Arkh. 2018 Sep 20;90(9):31-36. doi: 10.26442/terarkh201890931-36.
10
Elevated lipoprotein(a) levels predict cardiovascular disease in type 2 diabetes mellitus: a 10-year prospective cohort study.脂蛋白(a)水平升高可预测2型糖尿病患者的心血管疾病:一项为期10年的前瞻性队列研究。
Korean J Intern Med. 2016 Nov;31(6):1110-1119. doi: 10.3904/kjim.2016.030. Epub 2016 Oct 18.

引用本文的文献

1
Rethinking cardiovascular risk: The emerging role of lipoprotein(a) screening.重新审视心血管风险:脂蛋白(a)筛查的新作用。
Am J Prev Cardiol. 2025 Feb 14;21:100945. doi: 10.1016/j.ajpc.2025.100945. eCollection 2025 Mar.
2
C-PEPTIDE AS AN INFLAMMATORY MARKER IN OBESE WOMEN.C肽作为肥胖女性的炎症标志物
Acta Endocrinol (Buchar). 2023 Jan-Mar;19(1):31-35. doi: 10.4183/aeb.2023.31. Epub 2023 Aug 14.
3
Low Molecular Weight Apolipoprotein(a) Phenotype Rather Than Lipoprotein(a) Is Associated With Coronary Atherosclerosis and Myocardial Infarction.低分子量载脂蛋白(a)表型而非脂蛋白(a)与冠状动脉粥样硬化及心肌梗死相关。
Front Cardiovasc Med. 2022 Mar 11;9:843602. doi: 10.3389/fcvm.2022.843602. eCollection 2022.
4
Platelet to lymphocyte ratio is associated with the severity of coronary artery disease and clinical outcomes of percutaneous coronary intervention in the Chinese Han population.在中国汉族人群中,血小板与淋巴细胞比值与冠状动脉疾病的严重程度及经皮冠状动脉介入治疗的临床结局相关。
Exp Ther Med. 2017 Feb;13(2):731-738. doi: 10.3892/etm.2016.3993. Epub 2016 Dec 22.
5
Association of a methylene tetrahydrofolate reductase C677T polymorphism with several blood chemical levels in a Chinese population.中国人群中亚甲基四氢叶酸还原酶C677T多态性与多种血液化学指标的关联
Genet Test Mol Biomarkers. 2015 Jan;19(1):24-9. doi: 10.1089/gtmb.2014.0213.
6
Association Between Hematological Indices and Coronary Calcification in Symptomatic Patients without History of Coronary Artery Disease.无冠状动脉疾病病史的有症状患者血液学指标与冠状动脉钙化之间的关联
N Am J Med Sci. 2014 Sep;6(9):433-9. doi: 10.4103/1947-2714.141625.

本文引用的文献

1
Silent coronary artery disease in Japanese patients undergoing carotid artery stenting.日本颈动脉支架置入术患者的无症状性冠状动脉疾病。
J Stroke Cerebrovasc Dis. 2013 Oct;22(7):1163-8. doi: 10.1016/j.jstrokecerebrovasdis.2012.12.013. Epub 2013 Jan 22.
2
Assessment of the 9p21.3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetes.评估 9p21.3 基因座在 2 型糖尿病存在或不存在时对冠状动脉疾病严重程度的影响。
BMC Med Genet. 2013 Jan 23;14:11. doi: 10.1186/1471-2350-14-11.
3
Lipoprotein(a): resurrected by genetics.脂蛋白(a):遗传学复活。
J Intern Med. 2013 Jan;273(1):6-30. doi: 10.1111/j.1365-2796.2012.02592.x. Epub 2012 Nov 12.
4
Predictive value of the relative lymphocyte count in coronary heart disease.相对淋巴细胞计数在冠心病中的预测价值。
Heart Vessels. 2010 Nov;25(6):469-73. doi: 10.1007/s00380-010-0010-7. Epub 2010 Oct 5.
5
Apo(a) phenotyping and long-term prognosis for coronary artery disease.载脂蛋白(a)表型与冠状动脉疾病的长期预后。
Clin Biochem. 2010 May;43(7-8):640-4. doi: 10.1016/j.clinbiochem.2010.01.013. Epub 2010 Feb 12.
6
Revised equations for estimated GFR from serum creatinine in Japan.日本基于血清肌酐估算肾小球滤过率的修订方程。
Am J Kidney Dis. 2009 Jun;53(6):982-92. doi: 10.1053/j.ajkd.2008.12.034. Epub 2009 Apr 1.
7
Relationship between low lymphocyte count and major cardiac events in patients with acute chest pain, a non-diagnostic electrocardiogram and normal troponin levels.急性胸痛、心电图无诊断意义且肌钙蛋白水平正常患者的淋巴细胞计数低与主要心脏事件之间的关系。
Atherosclerosis. 2009 Sep;206(1):251-7. doi: 10.1016/j.atherosclerosis.2009.01.029. Epub 2009 Jan 29.
8
Effects of drug-eluting stents on systemic inflammatory response in patients with unstable angina pectoris undergoing percutaneous coronary intervention.药物洗脱支架对接受经皮冠状动脉介入治疗的不稳定型心绞痛患者全身炎症反应的影响。
Heart Vessels. 2008 Mar;23(2):75-82. doi: 10.1007/s00380-007-1020-y. Epub 2008 Apr 4.
9
Seasonal variations in inflammatory responses to sepsis and stress in mice.小鼠对脓毒症和应激炎症反应的季节性变化
Crit Care Med. 2007 Oct;35(10):2352-8. doi: 10.1097/01.ccm.0000282078.80187.7f.
10
WBC count, atherosclerosis and coronary risk factors.白细胞计数、动脉粥样硬化与冠状动脉危险因素。
J Atheroscler Thromb. 2002;9(5):219-23. doi: 10.5551/jat.9.219.